by palligoelme@gmail.com | Jul 31, 2026 | Clinical Trials
Conditions: Multiple Myeloma (MM) Interventions: Drug: Teclistamab; Drug: Talquetamab; Drug: Daratumumab (Subcutaneously); Drug: Lenalidomide Sponsors: Polish Myeloma Consortium; Medical Research Agency, Poland; Johnson & Johnson Not yet recruiting Conditions:...
by palligoelme@gmail.com | Jul 31, 2026 | Clinical Trials
Conditions: Familial Adenomatous Polyposis (FAP) Interventions: Drug: ST316 IV; Drug: ST316 IV Sponsors: Sapience Therapeutics Not yet recruiting Conditions: Familial Adenomatous Polyposis (FAP) Interventions: Drug: ST316 IV; Drug: ST316 IV Sponsors: Sapience...
by palligoelme@gmail.com | Jul 31, 2026 | Clinical Trials
Conditions: Dry Eye Interventions: Drug: OT202 conc 1%; Drug: Placebo Sponsors: Ocumension Therapeutics (Suzhou) Co., Ltd Not yet recruiting Conditions: Dry Eye Interventions: Drug: OT202 conc 1%; Drug: Placebo Sponsors: Ocumension Therapeutics (Suzhou) Co., Ltd Not...
by palligoelme@gmail.com | Jul 31, 2026 | Clinical Trials
Conditions: Blood Pressure Measurement Interventions: Device: rPPG blood pressure measurement medical device software Sponsors: Evondos Oy; Tampere University Recruiting Conditions: Blood Pressure Measurement Interventions: Device: rPPG blood pressure measurement...
by palligoelme@gmail.com | Jul 31, 2026 | Clinical Trials
Conditions: Primary Molar Tooth; Pulpotomies Primary Teeth Interventions: Device: Custom made zirconia crowns; Device: Prefabricated zirconia crown Sponsors: Cairo University Not yet recruiting Conditions: Primary Molar Tooth; Pulpotomies Primary Teeth...
by palligoelme@gmail.com | Jul 31, 2026 | Clinical Trials
Conditions: Hemodialysis; End Stage Kidney Disease (ESKD) Interventions: Other: Twice weekly hemodialysis; Other: Thrice weekly hemodialysis treatment Sponsors: Queen’s University Not yet recruiting Conditions: Hemodialysis; End Stage Kidney Disease (ESKD)...
